Want to see RDNT full AI Analyst Report?
RDNT Stock Chart & Stats
$61.57
-$0.06(-0.10%)
At close: 4:00 PM EDT
$61.57
-$0.06(-0.10%)
Day’s Range― - ―
52-Week Range$50.82 - $85.84
Previous Close$62.54
Volume476.74K
Average Volume (3M)909.69K
Market Cap
$6.05B
Enterprise Value$6.61K
Total Cash (Recent Filing)$726.27M
Total Debt (Recent Filing)$2.18B
Price to Earnings (P/E)―
Beta1.15
Next Earnings
Mar 02, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.27
Shares Outstanding78,697,754
10 Day Avg. Volume653,452
30 Day Avg. Volume909,693
Financial Highlights & Ratios
PEG Ratio0.38
Price to Book (P/B)4.92
Price to Sales (P/S)2.63
P/FCF Ratio62.70
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$84.67Price Target Upside37.51% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.51
Revenue Forecast (FY)$2.51B
Bulls Say, Bears Say
Bulls Say
AI Platform EfficiencyDeepHealth's digital platform supports AI models that can shorten MRI scan times and increase scans per machine, boosting facility capacity and improving operating margins.
Market PositioningShift of imaging from hospitals to lower-cost outpatient centers, combined with a large multi-state RadNet network, positions the company to capture increasing scan volume and offer faster, more cost-efficient services than hospital competitors.
New Revenue StreamAI-enabled mammography has led to detection of many breast cancers and is attracting out-of-pocket payments and some payor reimbursements, creating a growing revenue stream beyond traditional imaging fees.
Bears Say
Limited New InformationAnalyst notes the report largely reiterates already disclosed information, which may limit positive market reaction due to lack of fresh catalysts.
Stock-based CompensationElevated stock-based compensation tied to development of the DeepHealth business increases reported expenses and could pressure profitability and per-share metrics until compensation levels normalize.
Radnet News
RDNT FAQ
What was Radnet’s price range in the past 12 months?
Radnet lowest stock price was $50.82 and its highest was $85.84 in the past 12 months.
What is Radnet’s market cap?
Radnet’s market cap is $6.05B.
When is Radnet’s upcoming earnings report date?
Radnet’s upcoming earnings report date is Mar 02, 2027 which is in 187 days.
How were Radnet’s earnings last quarter?
Radnet released its earnings results on Aug 09, 2026. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.201 by $0.089.
Is Radnet overvalued?
According to Wall Street analysts Radnet’s price is currently Undervalued.
Does Radnet pay dividends?
Radnet does not currently pay dividends.
What is Radnet’s EPS estimate?
Radnet’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Radnet have?
Radnet has 78,697,754 shares outstanding.
What happened to Radnet’s price movement after its last earnings report?
Radnet reported an EPS of $0.29 in its last earnings report, beating expectations of $0.201. Following the earnings report the stock price went up 7.75%.
Which hedge fund is a major shareholder of Radnet?
Currently, no hedge funds are holding shares in RDNT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Radnet Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$84.67 (37.51% Upside)
$84.67 (37.51% Upside)
Blogger Sentiment
Bullish
RDNT Sentiment 67%
Sector Average 60%
Sector Average 60%
Hedge Fund Trend
Decreased
By 171.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 7.6%
Last 30 Days ▼ 7.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
7.14%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
20.24%
Trailing 12-Months
Company Description
Radnet
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
RDNT Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented strong operational and financial momentum: record company revenue and adjusted EBITDA, robust advanced imaging growth and mix improvement, meaningful Digital Health ARR acceleration and commercial funnel expansion, successful acquisitions/integrations, and a major FDA clearance for breast ultrasound AI. Near-term pressures include deliberate Digital Health investment-driven margin dilution, labor cost inflation, integration/implementation expenses, and reimbursement/regulatory uncertainty. Overall, the positive operational execution, liquidity position, guidance raises for the imaging segment, and clear path to scale Digital Health ARR and profitability outweigh the transitory challenges noted.View all RDNT earnings summariesRDNT Stock 12 Month Forecast
Average Price Target
$84.67
▲(37.51% Upside)
Technical Analysis
Ownership Overview
4.40% Insiders
29.66% Mutual Funds
35.32% Other Institutional Investors
6.44% Public Companies and
Individual Investors